CompletedPhase 1NCT02443961

Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Principal Investigator
Maria Jesus del Cerro, PhD
IRYCIS. Hospital Universitario Ramón y Cajal. Madrid. Spain
Intervention
Mesenchymal Stem Cell (MSC) therapy(biological)
Enrollment
10 enrolled
Eligibility
All sexes
Timeline
20192022

Study locations (4)

Collaborators

Instituto de Salud Carlos III · Fundación de Ayuda a la Investigación sobre la Hipertensión pulmonar

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02443961 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials